Compare · BDMD vs MDLN
BDMD vs MDLN
Side-by-side comparison of Baird Medical Investment Holdings Ltd (BDMD) and Medline Inc. (MDLN): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both BDMD and MDLN operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
- MDLN is the larger of the two at $51.51B, about 14915.9x BDMD ($3.5M).
- MDLN has been more active in the news (17 items in the past 4 weeks vs 7 for BDMD).
- MDLN has more recent analyst coverage (25 ratings vs 0 for BDMD).
- Company
- Baird Medical Investment Holdings Ltd
- Medline Inc.
- Price
- -
- -
- Market cap
- $3.5M
- $51.51B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Medical/Dental Instruments
- Medical/Dental Instruments
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2025
- News (4w)
- 7
- 17
- Recent ratings
- 0
- 25
Latest BDMD
- SEC Form 6-K filed by Baird Medical Investment Holdings Ltd
- Baird Medical Enters South Korea Market through Strategic Distribution Partnership with ALLIS MED
- SEC Form 6-K filed by Baird Medical Investment Holdings Ltd
- Baird Medical and Alpmed Announce FDA 510(k) and EU CE Submissions for Irreversible Electroporation (IRE) System
- Baird Medical Issues Statement Regarding Recent Share Price Volatility
- Baird Medical Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency
- Baird Medical and China Resources Pharmaceutical Commercial Group Medical Devices Sign Strategic Distribution Agreement to Expand Access to Microwave Ablation in China
- Baird Medical Announces Regulatory Milestones in Vietnam and Egypt, Expanding International Reach of Microwave Ablation Technology
- Baird Medical Highlights Global Expansion and Strategic Progress During Third Quarter 2026
- SEC Form SCHEDULE 13G filed by Baird Medical Investment Holdings Ltd
Latest MDLN
- Medline Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits
- Medline launches right-sized Ranpak packaging solutions in two key distribution centers
- SEC Form EFFECT filed by Medline Inc.
- Medline Inc. announces pricing of secondary offering of Class A common stock
- Chief Legal Officer Liberman Alexander M. was granted 798,680 units of Class B Common Stock, increasing direct ownership by 352% to 1,025,603 units (SEC Form 4)
- Chief Product Officer Laabs Amanda H. was granted 520,127 units of Class B Common Stock, increasing direct ownership by 207% to 771,197 units (SEC Form 4)
- Chief Commercial Officer Golwas Douglas P was granted 895,512 units of Class B Common Stock, increasing direct ownership by 164% to 967,560 units (SEC Form 4)
- Chief Executive Officer Boyle James M was granted 2,516,260 units of Class B Common Stock, increasing direct ownership by 7,591% to 1,869,921 units (SEC Form 4)
- Medline Inc. announces launch of secondary offering of Class A common stock
- SEC Form S-1 filed by Medline Inc.